Details for New Drug Application (NDA): 214408
✉ Email this page to a colleague
The generic ingredient in PEMETREXED DISODIUM is pemetrexed disodium. There are twenty-nine drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the pemetrexed disodium profile page.
Summary for 214408
Tradename: | PEMETREXED DISODIUM |
Applicant: | Accord Hlthcare |
Ingredient: | pemetrexed disodium |
Patents: | 0 |
Pharmacology for NDA: 214408
Mechanism of Action | Folic Acid Metabolism Inhibitors |
Medical Subject Heading (MeSH) Categories for 214408
Suppliers and Packaging for NDA: 214408
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PEMETREXED DISODIUM | pemetrexed disodium | SOLUTION;INTRAVENOUS | 214408 | NDA | Accord Healthcare Inc. | 16729-522 | 16729-522-05 | 1 VIAL in 1 CARTON (16729-522-05) / 20 mL in 1 VIAL |
PEMETREXED DISODIUM | pemetrexed disodium | SOLUTION;INTRAVENOUS | 214408 | NDA | Accord Healthcare Inc. | 16729-522 | 16729-522-28 | 1 VIAL in 1 CARTON (16729-522-28) / 34 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | EQ 100MG BASE/4ML (EQ 25MG BASE/ML) | ||||
Approval Date: | Jul 19, 2022 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | EQ 500MG BASE/20ML (EQ 25MG BASE/ML) | ||||
Approval Date: | Jul 19, 2022 | TE: | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | EQ 850MG BASE/34ML (EQ 25MG BASE/ML) | ||||
Approval Date: | Jul 19, 2022 | TE: | RLD: | Yes |
Complete Access Available with Subscription